Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Genetics and hormones cause hair loss; finasteride treats it safely.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Finasteride helps reduce heart issues and improves heart function.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Mouse genital development depends on male or female hormones for specific features.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Genes and hormones cause hair loss, with four genes contributing equally.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Genetic defects in androgen production are linked to male developmental disorders and are improving treatment understanding.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Apigenin may help promote hair growth and could treat hair loss.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.